Edinburgh-based digital health platform, Current Health, has announced securing £5 million in Series A funding in a recent investment round led by MMC Ventures. The funding will be used to expand the company’s AI-enabled remote patient monitoring platform.
Current Health’s platform is designed to help hospitals manage patient care remotely. It uses artificial intelligence (AI) algorithms to analyse patient data and alert medical staff if there are any changes in patient health, allowing for early intervention and treatment.
The latest investment round was joined by legal and professional services firm, Ashurst, and existing investors including Par Equity, The Scottish Investment Bank, and Old College Capital. The company has raised £10.2 million to date.
The COVID-19 pandemic has significantly accelerated the adoption of remote patient monitoring technologies, as hospitals and clinics sought ways to keep patients out of the hospital and reduce the risk of infection. With Current Health’s technology, healthcare providers can monitor patients remotely, reducing the need for in-person visits, and improving patient outcomes.
In a statement, Christopher McCann, co-founder, and CEO of Current Health said, “Our platform can help healthcare systems manage surges in demand like we’ve seen during the pandemic, by monitoring and triaging patients in the home. It also helps improve the patient experience and outcomes by delivering care in a more proactive, personalized and convenient way.”
Current Health is planning to use the funding to grow its team and expand its platform, which is already used by several leading healthcare providers in the US, UK, and Europe. The company’s goal is to help healthcare providers deliver more personalized care, reduce hospital admissions, and improve outcomes.
In conclusion, Current Health’s successful Series A funding round is a testament to the growing demand for remote patient monitoring technologies. With the company’s AI-enabled platform, healthcare providers can better manage patient care, reduce hospital admissions, and improve patient outcomes. The investment will enable the company to expand its platform and grow its team, further advancing the state of digital health.